Skip to main content
Fig. 1 | BMC Urology

Fig. 1

From: PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors

Fig. 1

PD-L1 expression in urothelial carcinomas. The panels show pT2–4 urothelial carcinomas with strong PD-L1 staining in tumor cells only (A), weak PD-L1 staining in tumor cells and prominent positivity in immune cells (B), strong PD-L1 staining in immune cells only (C), and complete absence of PD-L1 staining (D). Examples of pTa tumors show a prominent PD-L1 positivity of peritumoral macrophages (E) and absence of PD-L1 staining (F)

Back to article page